Valuation Valneva SE

Stocks

Real-time Euronext Paris 05:18:50 2026-09-08 EDT			5-day change	1st Jan Change
2.862 ^EUR	-0.97%		+2.00%	-23.02%

08-14	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate	CI
08-14	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,574	861.1	655.1	351.1	642.3	548.1	-	-
Change	-	-66.55%	-23.93%	-46.4%	82.94%	-14.67%	-	-
Enterprise Value (EV) ¹	2,286	670.5	737.8	399.1	739.9	681.8	610.6	599.8
Change	-	-70.66%	10.04%	-45.9%	85.38%	-7.86%	-10.45%	-1.76%
P/E	-32.7x	-5.02x	-6.47x	-27x	-5.47x	-6.63x	10.5x	13.9x
PBR	15.1x	-	5.1x	1.94x	6.07x	10.2x	4.29x	3.16x
PEG	-	-0.1x	0.2x	0.3x	-0x	0.2x	-0x	-0.6x
Capitalization / Revenue	7.4x	2.38x	4.26x	2.07x	3.68x	3.63x	1.93x	2.21x
EV / Revenue	6.57x	1.86x	4.8x	2.35x	4.24x	4.52x	2.15x	2.41x
EV / EBITDA	-48.5x	-9.69x	-11.3x	12.1x	-12.5x	-20.3x	5.89x	11.2x
EV / EBIT	-37.2x	-5.91x	-8.99x	29.9x	-9.12x	-11.8x	7.9x	11.2x
EV / FCF	-140x	-2.44x	-3.4x	-4.92x	-12.9x	-14.5x	6.65x	78.6x
FCF Yield	-0.71%	-41%	-29.4%	-20.3%	-7.75%	-6.88%	15%	1.27%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.75	-1.24	-0.73	-0.08	-0.68	-0.4357	0.2762	0.2083
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	348.1	361.3	153.7	169.6	174.7	151	283.4	248.4
EBITDA ¹	-47.1	-69.2	-65.24	32.92	-59.42	-33.62	103.7	53.7
EBIT ¹	-61.4	-113.4	-82.09	13.33	-81.16	-57.79	77.25	53.6
Net income ¹	-73.4	-143.3	-101.4	-12.25	-115.2	-81.11	53.07	28.74
Net Debt ¹	-288.9	-190.6	82.74	48.04	97.6	133.7	62.48	51.7
Reference price ²	24.500	6.224	4.720	2.162	3.718	2.890	2.890	2.890
Nbr of stocks (in thousands)	105,078	138,355	138,788	162,397	172,759	189,647	-	-
Announcement Date	2/3/22	3/23/23	3/21/24	3/20/25	3/17/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VALNEVA SE	-6.63x	4.52x	-20.28x	-.--%	637M
LONZA GROUP AG	32.76x	5.88x	17.63x	0.99%	48.41B
REVOLUTION MEDICINES, INC.	-21.5x	245.64x	-23.19x	-.--%	45.01B
IQVIA HOLDINGS INC.	34.48x	3.33x	14.35x	-.--%	44.07B
BEONE MEDICINES AG	46.93x	5.43x	29.72x	-.--%	40.73B
CELLTRION, INC.	28.26x	8.5x	21.55x	0.4%	33.21B
MEDPACE HOLDINGS, INC.	33.62x	5.51x	25.02x	-.--%	16.5B
EUROFINS SCIENTIFIC SE	23.87x	2.08x	9x	1.13%	14.45B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.18x	4.06x	15.75x	-.--%	13.77B
Average	27.66x	31.66x	9.95x	0.28%	28.53B
Weighted average by Cap.	27.05x	47.40x	12.13x	0.3%